Medical drugs are expensive to make and can have an adverse effect on the environment. Researchers Stefano Cucurachi and ...

The current pharmaceutical landscape demands a change in mindset. Success requires balancing speed, cost and quality while ...

While the benefits of AI are clear, the amount data sets needed for effective AI integration is proving to be a challenge.

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda ...

AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...

The growing strength of China’s drug pipelines has gone hand-in-hand with a steep uptick in big pharma licensing deals.

Instead of creating affordable products that improve health and lower costs, pharmaceutical companies focus on new drugs that will yield a healthy return on investment.

FDA consumer safety officer discussed the challenges of navigating policy and politics in rare diseases at a recent meeting.

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...

They've identified which grants wouldn't have been funded had similar cuts been made earlier in this century and tracked the ...